Do You Risk Stratify Your Patients for Post-Op Opioid Persistence?

Key Takeaways

• 41.9% of ACDF patients filled opioid prescriptions pre‑op.
• 69.5% of pre‑op opioid users stopped after surgery.
• Only 2.2% of opioid‑naïve patients became chronic users.
• 16% continued opioid purchases despite successful ACDF.
• Risk factors: pain >1 yr, smoking, high disability, stenosis, unemployment.

Pulse Analysis

The prevalence of opioid and neuropathic pain medication use among spine surgery patients has long been a concern for clinicians and payers. By leveraging Finland’s national prescription database, the FinSpine register provides an unprecedented, bias‑free view of medication purchasing patterns surrounding anterior cervical discectomy and fusion (ACDF). This methodology eliminates self‑reporting errors and loss‑to‑follow‑up, delivering a population‑wide snapshot that can be benchmarked against other health systems.

Results show that nearly half of ACDF candidates were already on opioids or gabapentinoids before entering the operating room, underscoring the chronic pain burden in this cohort. Post‑operative data reveal a striking 70% cessation rate for both drug classes, and a mere 2.2% incidence of new strong‑opioid dependence among previously naïve patients. Nonetheless, about one‑in‑six patients persisted with opioid purchases, a subgroup whose characteristics—pain duration over a year, smoking, higher Neck Disability Index scores, central canal stenosis, and unemployment—are readily identifiable during pre‑operative evaluation.

For surgeons and health‑system leaders, these insights translate into actionable strategies. Pre‑operative risk stratification enables focused counseling, early referral to pain‑management programs, and consideration of adjunctive therapies for high‑risk individuals. Moreover, the study’s objective outcome measures set a new standard for postoperative monitoring, encouraging other registries to adopt similar data‑linkage approaches. Ultimately, integrating medication‑use risk profiles into surgical decision‑making can enhance patient outcomes, reduce opioid exposure, and support broader public‑health goals of responsible analgesic stewardship.